---
figid: PMC6916405__CEN-92-11-g004
figlink: pmc/articles/PMC6916405/figure/cen14109-fig-0004/
number: F4
caption: Sphingosine‐1‐phosphate lyase‐1 (SGPL1) disruption causes adrenal insufficiency.
  (A) SGPL1 regulates breakdown of ceramide, a pathway associated with several established
  metabolic disorders (sphingolipidoses). (B) The Sgpl1‐/‐ knockout mouse has an adrenal
  phenotype including depleted lipid in zona glomerulosa cells. Panels (A) and (B)
  modified from Prasad R, Hadjidemetriou I, Maharaj A, et al Sphingosine‐1‐phosphate
  lyase mutations cause primary adrenal insufficiency and steroid‐resistant nephrotic
  syndrome. J Clin Invest. 2017;127(3):942‐953 © 2017 The Authors (http://creativecommons.org/licenses/by/4.0/)
pmcid: PMC6916405
papertitle: 'Primary adrenal insufficiency: New genetic causes and their long‐term
  consequences.'
reftext: Federica Buonocore, et al. Clin Endocrinol (Oxf). 2020 Jan;92(1):11-20.
pmc_ranked_result_index: '42557'
pathway_score: 0.5524145
filename: CEN-92-11-g004.jpg
figtitle: Sphingosine‐1‐phosphate lyase‐1 (SGPL1) disruption causes adrenal insufficiency
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6916405__CEN-92-11-g004.html
  '@type': Dataset
  description: Sphingosine‐1‐phosphate lyase‐1 (SGPL1) disruption causes adrenal insufficiency.
    (A) SGPL1 regulates breakdown of ceramide, a pathway associated with several established
    metabolic disorders (sphingolipidoses). (B) The Sgpl1‐/‐ knockout mouse has an
    adrenal phenotype including depleted lipid in zona glomerulosa cells. Panels (A)
    and (B) modified from Prasad R, Hadjidemetriou I, Maharaj A, et al Sphingosine‐1‐phosphate
    lyase mutations cause primary adrenal insufficiency and steroid‐resistant nephrotic
    syndrome. J Clin Invest. 2017;127(3):942‐953 © 2017 The Authors (http://creativecommons.org/licenses/by/4.0/)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SGPL1
  - Ceramide
  - Steroid
  - Sphingomyelins
  - Diacylglycerol
  - Triacylglycerol
  - Sphingosine
  - Phosphoethanolamine
  - Adrenal insufficiency
  - Adrenal calcification
  - "nephrotic \x1F syndrome"
  - SRNS
  - Icthyosis
  - Neurological dysfunction
  - Primary hypothyroidism
  - Lymphopaenia
genes:
- word: SGPL1
  symbol: SGPL1
  source: hgnc_symbol
  hgnc_symbol: SGPL1
  entrez: '8879'
- word: SGPL1
  symbol: SGPL1
  source: hgnc_symbol
  hgnc_symbol: SGPL1
  entrez: '8879'
chemicals:
- word: Ceramide
  source: MESH
  identifier: D002518
- word: Steroid
  source: MESH
  identifier: D013256
- word: Sphingomyelins
  source: MESH
  identifier: D013109
- word: Diacylglycerol
  source: MESH
  identifier: D004075
- word: Triacylglycerol
  source: MESH
  identifier: D014280
- word: Sphingosine
  source: MESH
  identifier: D013110
- word: Phosphoethanolamine
  source: MESH
  identifier: C005448
diseases:
- word: Adrenal insufficiency
  source: MESH
  identifier: D000309
- word: Adrenal calcification
  source: MESH
  identifier: D002114
- word: "nephrotic \x1F syndrome"
  source: MESH
  identifier: D009404
- word: SRNS
  source: ''
  identifier: ''
- word: Icthyosis
  source: MESH
  identifier: D016111
- word: Neurological dysfunction
  source: MESH
  identifier: D009422
- word: Primary hypothyroidism
  source: MESH
  identifier: D007037
- word: Lymphopaenia
  source: ''
  identifier: ''
figid_alias: PMC6916405__F4
redirect_from: /figures/PMC6916405__F4
figtype: Figure
---
